248 related articles for article (PubMed ID: 20151671)
1. Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction.
Jarvis A; Allerston CK; Jia H; Herzog B; Garza-Garcia A; Winfield N; Ellard K; Aqil R; Lynch R; Chapman C; Hartzoulakis B; Nally J; Stewart M; Cheng L; Menon M; Tickner M; Djordjevic S; Driscoll PC; Zachary I; Selwood DL
J Med Chem; 2010 Mar; 53(5):2215-26. PubMed ID: 20151671
[TBL] [Abstract][Full Text] [Related]
2. Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity.
Jia H; Cheng L; Tickner M; Bagherzadeh A; Selwood D; Zachary I
Br J Cancer; 2010 Feb; 102(3):541-52. PubMed ID: 20087344
[TBL] [Abstract][Full Text] [Related]
3. Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth.
Hamerlik P; Lathia JD; Rasmussen R; Wu Q; Bartkova J; Lee M; Moudry P; Bartek J; Fischer W; Lukas J; Rich JN; Bartek J
J Exp Med; 2012 Mar; 209(3):507-20. PubMed ID: 22393126
[TBL] [Abstract][Full Text] [Related]
4. VEGF (Vascular Endothelial Growth Factor) Induces NRP1 (Neuropilin-1) Cleavage via ADAMs (a Disintegrin and Metalloproteinase) 9 and 10 to Generate Novel Carboxy-Terminal NRP1 Fragments That Regulate Angiogenic Signaling.
Mehta V; Fields L; Evans IM; Yamaji M; Pellet-Many C; Jones T; Mahmoud M; Zachary I
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1845-1858. PubMed ID: 29880492
[TBL] [Abstract][Full Text] [Related]
5. Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting.
Pan Q; Chathery Y; Wu Y; Rathore N; Tong RK; Peale F; Bagri A; Tessier-Lavigne M; Koch AW; Watts RJ
J Biol Chem; 2007 Aug; 282(33):24049-56. PubMed ID: 17575273
[TBL] [Abstract][Full Text] [Related]
6. Targeting neuropilin 1 as an antitumor strategy in lung cancer.
Hong TM; Chen YL; Wu YY; Yuan A; Chao YC; Chung YC; Wu MH; Yang SC; Pan SH; Shih JY; Chan WK; Yang PC
Clin Cancer Res; 2007 Aug; 13(16):4759-68. PubMed ID: 17699853
[TBL] [Abstract][Full Text] [Related]
7. Architecture and hydration of the arginine-binding site of neuropilin-1.
Mota F; Fotinou C; Rana RR; Chan AWE; Yelland T; Arooz MT; O'Leary AP; Hutton J; Frankel P; Zachary I; Selwood D; Djordjevic S
FEBS J; 2018 Apr; 285(7):1290-1304. PubMed ID: 29430837
[TBL] [Abstract][Full Text] [Related]
8. The interaction of Neuropilin-1 and Neuropilin-2 with tyrosine-kinase receptors for VEGF.
Neufeld G; Kessler O; Herzog Y
Adv Exp Med Biol; 2002; 515():81-90. PubMed ID: 12613545
[TBL] [Abstract][Full Text] [Related]
9. Peptides Derived from Vascular Endothelial Growth Factor B Show Potent Binding to Neuropilin-1.
Mota F; Yelland T; Hutton JA; Parker J; Patsiarika A; Chan AWE; O'Leary A; Fotinou C; Martin JF; Zachary IC; Djordjevic S; Frankel P; Selwood DL
Chembiochem; 2022 Jan; 23(1):e202100463. PubMed ID: 34647407
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin Fc-Fused Peptide without C-Terminal Arg or Lys Residue Augments Neuropilin-1-Dependent Tumor Vascular Permeability.
Baek DS; Kim JH; Kim YJ; Kim YS
Mol Pharm; 2018 Feb; 15(2):394-402. PubMed ID: 29232521
[TBL] [Abstract][Full Text] [Related]
11. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis.
Banerjee S; Mehta S; Haque I; Sengupta K; Dhar K; Kambhampati S; Van Veldhuizen PJ; Banerjee SK
Biochemistry; 2008 Mar; 47(11):3345-51. PubMed ID: 18284215
[TBL] [Abstract][Full Text] [Related]
12. Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-Cells.
Powell J; Mota F; Steadman D; Soudy C; Miyauchi JT; Crosby S; Jarvis A; Reisinger T; Winfield N; Evans G; Finniear A; Yelland T; Chou YT; Chan AWE; O'Leary A; Cheng L; Liu D; Fotinou C; Milagre C; Martin JF; Jia H; Frankel P; Djordjevic S; Tsirka SE; Zachary IC; Selwood DL
J Med Chem; 2018 May; 61(9):4135-4154. PubMed ID: 29648813
[TBL] [Abstract][Full Text] [Related]
13. The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis.
Lanahan A; Zhang X; Fantin A; Zhuang Z; Rivera-Molina F; Speichinger K; Prahst C; Zhang J; Wang Y; Davis G; Toomre D; Ruhrberg C; Simons M
Dev Cell; 2013 Apr; 25(2):156-68. PubMed ID: 23639442
[TBL] [Abstract][Full Text] [Related]
14. Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity.
Sulpice E; Plouët J; Bergé M; Allanic D; Tobelem G; Merkulova-Rainon T
Blood; 2008 Feb; 111(4):2036-45. PubMed ID: 18065694
[TBL] [Abstract][Full Text] [Related]
15. Use of NanoBiT and NanoBRET to monitor fluorescent VEGF-A binding kinetics to VEGFR2/NRP1 heteromeric complexes in living cells.
Peach CJ; Kilpatrick LE; Woolard J; Hill SJ
Br J Pharmacol; 2021 Jun; 178(12):2393-2411. PubMed ID: 33655497
[TBL] [Abstract][Full Text] [Related]
16. Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity.
Gagnon ML; Bielenberg DR; Gechtman Z; Miao HQ; Takashima S; Soker S; Klagsbrun M
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2573-8. PubMed ID: 10688880
[TBL] [Abstract][Full Text] [Related]
17. Real-Time Ligand Binding of Fluorescent VEGF-A Isoforms that Discriminate between VEGFR2 and NRP1 in Living Cells.
Peach CJ; Kilpatrick LE; Friedman-Ohana R; Zimmerman K; Robers MB; Wood KV; Woolard J; Hill SJ
Cell Chem Biol; 2018 Oct; 25(10):1208-1218.e5. PubMed ID: 30057299
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel nonpeptide small-molecule NRP1 antagonists: Virtual screening, molecular simulation and structural modification.
Peng K; Li Y; Bai Y; Jiang T; Sun H; Zhu Q; Xu Y
Bioorg Med Chem; 2020 Jan; 28(1):115183. PubMed ID: 31744780
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin Fc-fused, neuropilin-1-specific peptide shows efficient tumor tissue penetration and inhibits tumor growth via anti-angiogenesis.
Kim YJ; Bae J; Shin TH; Kang SH; Jeong M; Han Y; Park JH; Kim SK; Kim YS
J Control Release; 2015 Oct; 216():56-68. PubMed ID: 26260451
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of neuropilin-1 by RNA-interference and its angiostatic potential in the treatment of hepatocellular carcinoma.
Raskopf E; Vogt A; Standop J; Sauerbruch T; Schmitz V
Z Gastroenterol; 2010 Jan; 48(1):21-7. PubMed ID: 20072992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
